INTERSTELLAR - International Study Evaluating Lupus Outcomes after Anifrolumab Real World Use

Trial Identifier:	D3461R00072
Sponsor:	AstraZeneca
Start Date:	October 2024
Primary Completion Date:	November 2026
Study Completion Date:	November 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Guangzhou, China
China	Shenzhen, China
China	Zhongshan, China
Qatar	Doha, Qatar
Saudi Arabia	Abha, Saudi Arabia
Saudi Arabia	Riyadh, Saudi Arabia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.